BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21925755)

  • 1. Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin's lymphoma.
    Cella L; Liuzzi R; Conson M; Torre G; Caterino M; De Rosa N; Picardi M; Camera L; Solla R; Farella A; Salvatore M; Pacelli R
    Radiother Oncol; 2011 Nov; 101(2):316-21. PubMed ID: 21925755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma.
    Cella L; Conson M; Caterino M; De Rosa N; Liuzzi R; Picardi M; Grimaldi F; Solla R; Farella A; Salvatore M; Pacelli R
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1802-8. PubMed ID: 21514076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures.
    Vordermark D; Seufert I; Schwab F; Kölbl O; Kung M; Angermann C; Flentje M
    Radiat Oncol; 2006 Apr; 1():10. PubMed ID: 16722610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
    Koh ES; Sun A; Tran TH; Tsang R; Pintilie M; Hodgson DC; Wells W; Heaton R; Gospodarowicz MK
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):223-8. PubMed ID: 16904523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.
    Adams MJ; Lipsitz SR; Colan SD; Tarbell NJ; Treves ST; Diller L; Greenbaum N; Mauch P; Lipshultz SE
    J Clin Oncol; 2004 Aug; 22(15):3139-48. PubMed ID: 15284266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy.
    Tsai HR; Gjesdal O; Wethal T; Haugaa KH; Fosså A; Fosså SD; Edvardsen T
    Am J Cardiol; 2011 Feb; 107(3):472-7. PubMed ID: 21257017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate normal tissue complication probability modeling of heart valve dysfunction in Hodgkin lymphoma survivors.
    Cella L; Liuzzi R; Conson M; D'Avino V; Salvatore M; Pacelli R
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):304-10. PubMed ID: 23886419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
    Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Valvular Disorders in Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy ± Chemotherapy.
    Bijl JM; Roos MM; van Leeuwen-Segarceanu EM; Vos JM; Bos WW; Biesma DH; Post MC
    Am J Cardiol; 2016 Feb; 117(4):691-696. PubMed ID: 26772441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe valvular toxicity and pericarditis early after radiation therapy in a patient treated for Hodgkin's lymphoma.
    Ramyar A; Shafiei M; Moazzami K; Rezaei N
    Turk J Pediatr; 2010; 52(4):423-5. PubMed ID: 21043392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
    Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A
    J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Double stenosing valve disease after mediastinal radiotherapy: a case report of a 31 year-old man].
    Ky T; Marazanof M; Dos Santos P; Guérin P; Couffinhal T; Larquey P; Roques X; Roudaut R
    Arch Mal Coeur Vaiss; 1998 Mar; 91(3):351-5. PubMed ID: 9749241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
    Noordijk EM; Carde P; Dupouy N; Hagenbeek A; Krol AD; Kluin-Nelemans JC; Tirelli U; Monconduit M; Thomas J; Eghbali H; Aleman BM; Bosq J; Vovk M; Verschueren TA; Pény AM; Girinsky T; Raemaekers JM; Henry-Amar M
    J Clin Oncol; 2006 Jul; 24(19):3128-35. PubMed ID: 16754934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.